Trends in heart failure outcomes and pharmacotherapy: 1992 to 2000
Authors:
- Douglas S LeeDLDouglas S Lee
- Muhammad M MamdaniMMMuhammad M Mamdani
- Peter C AustinPAPeter C Austin
- Yanyan GongYGYanyan Gong
- Peter P LiuPLPeter P Liu
- Jean L RouleauJRJean L Rouleau
- Jack V TuJTJack V Tu
- 1 May 2004
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 116 (9) , 581-589
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Care and Outcomes of Patients Newly Hospitalized for Heart Failure in the Community Treated by Cardiologists Compared With Other SpecialistsCirculation, 2003
- Prognosis and Determinants of Survival in Patients Newly Hospitalized for Heart FailureArchives of internal medicine (1960), 2002
- Evidence of Improving Prognosis in Heart FailureCirculation, 2000
- Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and OpportunitiesNew England Journal of Medicine, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987